GE HealthCare Q1 2025: Financials Revealed

Ticker: GEHC · Form: 10-Q · Filed: 2025-04-30T00:00:00.000Z

Sentiment: neutral

Topics: 10-Q, financials, healthcare

TL;DR

GE HealthCare Q1 2025: Revenue, costs, and debt details out. Check the numbers.

AI Summary

GE HealthCare Technologies Inc. reported its first quarter 2025 results, ending March 31, 2025. The company's filing details its financial performance across product and service segments, with specific figures for revenue, cost of revenue, and selling, general, and administrative expenses. The report also includes information on long-term debt and other liabilities.

Why It Matters

This filing provides investors and analysts with a detailed look at GE HealthCare's financial health and operational performance in the first quarter of 2025, influencing investment decisions.

Risk Assessment

Risk Level: medium — The filing contains detailed financial information, including debt and expenses, which are critical for assessing the company's financial health and future performance.

Key Numbers

Key Players & Entities

FAQ

What were GE HealthCare's reported revenues for the product segment in Q1 2025?

The filing indicates revenues for the product segment for the period January 1, 2025 to March 31, 2025.

What is the company's fiscal year end?

The fiscal year end for GE HealthCare Technologies Inc. is December 31.

When did GE HealthCare Technologies Inc. change its name from GE Healthcare Holding LLC?

The date of the name change was June 3, 2022.

What is the SEC file number for GE HealthCare Technologies Inc.?

The SEC file number is 001-41528.

What are the key financial reporting categories mentioned in the filing?

The filing references categories such as LongTermDebtNoncurrent, CostOfRevenue, SellingGeneralAndAdministrativeExpense, OtherLiabilitiesNoncurrent, and AccountsPayableCurrent.

From the Filing

0001932393-25-000014.txt : 20250430 0001932393-25-000014.hdr.sgml : 20250430 20250430062615 ACCESSION NUMBER: 0001932393-25-000014 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 115 CONFORMED PERIOD OF REPORT: 20250331 FILED AS OF DATE: 20250430 DATE AS OF CHANGE: 20250430 FILER: COMPANY DATA: COMPANY CONFORMED NAME: GE HealthCare Technologies Inc. CENTRAL INDEX KEY: 0001932393 STANDARD INDUSTRIAL CLASSIFICATION: X-RAY APPARATUS & TUBES & RELATED IRRADIATION APPARATUS [3844] ORGANIZATION NAME: 08 Industrial Applications and Services EIN: 882515116 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-41528 FILM NUMBER: 25890735 BUSINESS ADDRESS: STREET 1: 500 WEST MONROE STREET CITY: CHICAGO STATE: IL ZIP: 60661 BUSINESS PHONE: 833-735-1139 MAIL ADDRESS: STREET 1: 500 WEST MONROE STREET CITY: CHICAGO STATE: IL ZIP: 60661 FORMER COMPANY: FORMER CONFORMED NAME: GE Healthcare Holding LLC DATE OF NAME CHANGE: 20220603 10-Q 1 gehc-20250331.htm 10-Q gehc-20250331 false 0001932393 Q1 2025 12/31 http://fasb.org/us-gaap/2024#LongTermDebtNoncurrent http://fasb.org/us-gaap/2024#LongTermDebtNoncurrent http://fasb.org/us-gaap/2024#CostOfRevenue http://fasb.org/us-gaap/2024#SellingGeneralAndAdministrativeExpense http://fasb.org/us-gaap/2024#CostOfRevenue http://fasb.org/us-gaap/2024#SellingGeneralAndAdministrativeExpense http://fasb.org/us-gaap/2024#OtherLiabilitiesNoncurrent http://fasb.org/us-gaap/2024#OtherLiabilitiesNoncurrent http://fasb.org/us-gaap/2024#AccountsPayableCurrent http://fasb.org/us-gaap/2024#AccountsPayableCurrent xbrli:shares iso4217:USD iso4217:USD xbrli:shares gehc:segment xbrli:pure gehc:series 0001932393 2025-01-01 2025-03-31 0001932393 2025-04-23 0001932393 us-gaap:ProductMember 2025-01-01 2025-03-31 0001932393 us-gaap:ProductMember 2024-01-01 2024-03-31 0001932393 us-gaap:ServiceMember 2025-01-01 2025-03-31 0001932393 us-gaap:ServiceMember 2024-01-01 2024-03-31 0001932393 2024-01-01 2024-03-31 0001932393 2025-03-31 0001932393 2024-12-31 0001932393 us-gaap:CommonStockMember 2024-12-31 0001932393 us-gaap:TreasuryStockCommonMember 2024-12-31 0001932393 us-gaap:AdditionalPaidInCapitalMember 2024-12-31 0001932393 us-gaap:RetainedEarningsMember 2024-12-31 0001932393 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-12-31 0001932393 us-gaap:NoncontrollingInterestMember 2024-12-31 0001932393 us-gaap:CommonStockMember 2025-01-01 2025-03-31 0001932393 us-gaap:AdditionalPaidInCapitalMember 2025-01-01 2025-03-31 0001932393 us-gaap:RetainedEarningsMember 2025-01-01 2025-03-31 0001932393 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-01-01 2025-03-31 0001932393 us-gaap:NoncontrollingInterestMember 2025-01-01 2025-03-31 0001932393 us-gaap:CommonStockMember 2025-03-31 0001932393 us-gaap:TreasuryStockCommonMember 2025-03-31 0001932393 us-gaap:AdditionalPaidInCapitalMember 2025-03-31 0001932393 us-gaap:RetainedEarningsMember 2025-03-31 0001932393 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-03-31 0001932393 us-gaap:NoncontrollingInterestMember 2025-03-31 0001932393 us-gaap:CommonStockMember 2023-12-31 0001932393 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0001932393 us-gaap:RetainedEarningsMember 2023-12-31 0001932393 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-12-31 0001932393 us-gaap:NoncontrollingInterestMember 2023-12-31 0001932393 2023-12-31 0001932393 us-gaap:CommonStockMember 2024-01-01 2024-03-31 0001932393 us-gaap:AdditionalPaidInCapitalMember 2024-01-01 2024-03-31 0001932393 us-gaap:RetainedEarningsMember 2024-01-01 2024-03-31 0001932393 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-01-01 2024-03-31 0001932393 us-gaap:NoncontrollingInterestMember 2024-01-01 2024-03-31 0001932393 us-gaap:CommonStockMember 2024-03-31 0001932393 us-gaap:AdditionalPaidInCapitalMember 2024-03-31 0001932393 us-gaap:RetainedEarningsMember 2024-03-31 0001932393 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-03-31 0001932

View on Read The Filing